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INTRODUCTION In the present work, hydrogels 
composed of Pluronic® F127 derivatives were 
investigated as possible HepG2 cell supports to 
assess their applicability for tissue engineering 
purposes. To enable the production of complex 
three-dimensional and fully interconnected 
scaffolds, the Bioplotter™ technology was 
applied. Hence, recent developments will be 
presented on the fabrication of covalently 
cross-linked 3D scaffolds using two strategies 
including UV-induced photo-polymerisation 
and a biosynthetic enzymatic pathway. 
MATERIALS AND METHODS Polymerizable 
Pluronic® F127 derivatives were obtained via 
the modification of the terminal hydroxyl 
functionalities. For the synthesis of photo-
polymerizable Pluronic® F127-BMA and F127-
Ala-L, methacryloyl chloride was applied, 
thereby introducing methacrylate end-groups 
in the presence (F127-Ala-L) and in the absence 
(F127-BMA) of a spacer. For the bio-inspired 
enzymatic pathway, phenolic end-groups were 
introduced. The latter enabled a biosynthetic 
reaction, resulting in the cross-linking of the 
F127-SATA and the F127-PNCTA derivatives. 
The hydrogels developed were characterized 
for their sol/gel fractions, their temperature-
dependent swelling properties, their 
mechanical properties (i.e. texturometry) and 
drug release profiles. The 3D construction of 
the scaffolds occurred in a laminar fashion 
through a computer-controlled deposition of 
the material. The scaffolds developed were 
characterized using optical microscopy and 
SEM. Finally, the hydrogels were applied as 
encapsulation matrices for HepG2 cells and cell 
viability studies were performed using calcein 
AM/PI  staining. 
RESULTS AND DISCUSSION The Pluronic® 
derivatives were successfully synthesized, 
showing a high degree of substitution (>90%) 
for both the photo-polymerization as well as 
for the enzymatic crosslinking strategy. 
Interestingly, enzymatic crosslinking results in 
a shorter gelation time compared to the photo-
crosslinking, even for lower Pluronic® 
concentrations. The hydrogels developed were 
characterized in depth and were suitable to be 
applied as starting materials to fabricate 3D 
scaffolds using the Bioplotting™ process (see 
fig. 1). Preliminary biocompatibility and cell 
viability studies using HepG2 indicated that the 
enzymatic crosslinking strategy elaborated and 
applied showed a significant positive effect on 





Fig. 1: Hydrated 3D scaffolds based on Pluronic® F127-
BMA, fabricated by the Bioplotting™process  
CONCLUSIONS The results indicated that 3D 
scaffolds can be successfully developed 
starting from various Pluronic® F127 
derivatives and by applying different 
crosslinking strategies. At present, the 
potential of the scaffolds developed to function 
as cell carriers is further evaluated (e.g. 
through gene expression studies, etc…). Future 
work will focus on the fine-tuning of the 
biocompatibility as well as on the 3D 
Bioplotting of hydrogels containing 
encapsulated  cells. 
ACKNOWLEDGEMENT The authors would like 
to acknowledge the research Foundation 
Flanders (FWO-Flanders) and the IWT (Agency 
for Innovation by Science and Technology, 
Belgium, IWT-SBO HEPSTEM project) for the 
financial support.  
 
